- Home
- CHKP vs TEVA Comparison
CHKP vs TEVA Comparison
Compare CHKP & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHKP
- TEVA
- Stock Information
- Founded
- CHKP 1993
- TEVA 1901
- Country
- CHKP Israel
- TEVA Israel
- Employees
- CHKP N/A
- TEVA N/A
- Industry
- CHKP Computer Software: Prepackaged Software
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- CHKP Technology
- TEVA Health Care
- Exchange
- CHKP Nasdaq
- TEVA Nasdaq
- Market Cap
- CHKP 23.5B
- TEVA 23.7B
- IPO Year
- CHKP 1996
- TEVA N/A
- Fundamental
- Price
- CHKP $216.80
- TEVA $16.75
- Analyst Decision
- CHKP Hold
- TEVA Strong Buy
- Analyst Count
- CHKP 24
- TEVA 6
- Target Price
- CHKP $215.59
- TEVA $24.17
- AVG Volume (30 Days)
- CHKP 1.1M
- TEVA 15.5M
- Earning Date
- CHKP 01-30-2025
- TEVA 01-29-2025
- Dividend Yield
- CHKP N/A
- TEVA N/A
- EPS Growth
- CHKP 5.07
- TEVA N/A
- EPS
- CHKP 7.46
- TEVA N/A
- Revenue
- CHKP $2,565,000,000.00
- TEVA $16,544,000,000.00
- Revenue This Year
- CHKP $8.11
- TEVA $5.31
- Revenue Next Year
- CHKP $5.52
- TEVA $1.18
- P/E Ratio
- CHKP $29.06
- TEVA N/A
- Revenue Growth
- CHKP 6.22
- TEVA 4.40
- 52 Week Low
- CHKP $145.75
- TEVA $12.51
- 52 Week High
- CHKP $226.03
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- CHKP 60.07
- TEVA 35.64
- Support Level
- CHKP $215.84
- TEVA $16.08
- Resistance Level
- CHKP $223.08
- TEVA $17.63
- Average True Range (ATR)
- CHKP 4.51
- TEVA 0.54
- MACD
- CHKP -0.46
- TEVA 0.01
- Stochastic Oscillator
- CHKP 53.24
- TEVA 39.82
About CHKP Check Point Software Technologies Ltd.
Check Point Software Technologies is a pure-play cybersecurity vendor. The company offers solutions for network, endpoint, cloud, and mobile security in addition to security management. Check Point, a software specialist, sells to enterprises, businesses, and consumers. Around 50% of revenue is generated in Europe, the Middle East, and Africa, 40% from the Americas, and 10% from the Asia-Pacific region. The firm, based in Tel Aviv, Israel, was founded in 1993 and has about 5,000 employees.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.